Search
- Working Paper
CBO developed a new version its health insurance simulation model, HISIM2, including using new sources of input data. This paper describes the new input data and the methods for adjusting and adding to those data to form the sample used in HISIM2.
- Working Paper
Updating its approach to estimating the effects of changes to medical malpractice liability laws on federal spending, CBO explains how and why the modeling is changing and offers a preliminary estimate of the budgetary effects.
- Working Paper
In 2015, brand-name specialty drugs accounted for about 30 percent of net spending on prescription drugs under Medicare Part D and Medicaid, but they accounted for only about 1 percent of all prescriptions dispensed in each program.